REGENERON PHARMACEUTICALS, INC. - COM (REGN)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / COM
Number of holders
1157
Total Shares
89.9M
Shares change
-1.79M
Total reported value, excl. options
$74B
Value change
-$1.31B
Put/Call ratio
1.09
Number of buys
481
Number of sells
-519
Price
$822.96
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.